Atlas Trials

Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.

Clinical trial NCT05347511 · UNKNOWN

Trial details

NCT number
NCT05347511
Sponsor
Central Hospital, Nancy, France
Status
UNKNOWN
Study type
OBSERVATIONAL
Rare Disease With Poor Outcome
Start date
2022-04-20
Primary completion
2022-09-01
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.